Moreover, our previously published research showed that metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter, and inhibits cancer growth and metastasis in NSCLC [4]. This evidence concerns the gene YAP1 and non-small cell lung carcinoma.